2. Materials and Methods
2.1. Patient Population
A total of 3500 patients who underwent transvenous lead extraction (TLE) procedures by one key operator at three high volume centers between June 2008 and September 2021 were included into this study. All information regarding the patient and the procedure was entered into the computer database on a current basis. Patients without complete echocardiographic findings before and after TLE were excluded. Finally, a total of 2678 patients were enrolled in this study. Patients were divided into two main groups: Group 1 consisted of 119 (4.44%) of patients with lead dependent tricuspid valve dysfunction and Group 2 consisted of 2559 patients without LDTVD. Additionally, an analysis of two LDTVD subgroups was performed—with and without improvement in tricuspid valve function after TLE (
Supplementary File).
2.2. Baseline Parameters
Demographic data, comorbidities and history of pacing were analyzed. The incidence of coronary heart disease, cardiomyopathy, valvular heart diseases and other comorbidities: hypertension, atrial fibrillation, congestive heart failure, diabetes, renal failure, long-term anticoagulation, and Charlson’s comorbidity index, was compared in the studied groups. The comparison of indication-related, system-related and history of pacing related factors in patients with and without LDTVD was also conducted including frequency of occurrence: lead -related infective endocarditis (LRIE), local, pocket infection and non-infective indications for TLE, type of implanted device, number of implanted leads, location of the tip of the lead, abnormal elongated loop of the lead and dwell time of the leads. The complexity of procedures, effectiveness of TLE, presence of complications and short-, medium- and long-term mortality after TLE were also compared in the study groups.
2.3. Echocardiography
Transthoracic echocardiography (TTE) was performed in all patients before and after transvenous lead extraction. Transesophageal echocardiography (TEE) was performed before and after TLE in all of patients undergoing TLE in years 2008–2015. A total of 90% of TLE procedures have been continuously monitored by TEE since 2016 with the precise assessment of TV function before, during and after procedure.
TTE and TEE in our series was performed using Philips iE33 (Phillips Healthcare, Andover, MA, USA) and GE Vivid S 70 GE Healthcare machines (General Electric Company, Boston, MA, USA) equipped with X7-2t Live 3D (Phillips Healthcare, Andover, MA, USA) or 6VT-D probes (General Electric Company, Boston, MA, USA). All recordings were archived and carefully assessed by two experienced cardiologists who were blinded to the clinical data.
Tricuspid regurgitation (TR) severity was graded semi-quantitatively using colored and continuous wave Doppler data using a multi-parametric approach [
18,
19] including valve morphology, colour flow jet, continuous wave signal of the jet, vena contracta width, and were categorized in three groups: no, trace or mild (0, 1st, 2nd Grades), moderate (3rd Grade), and severe (4th Grade). Lead removal associated improvement of TR was defined by reduction of TR from severe to moderate/mild or from moderate to mild comparing echocardiography studies before and after TLE. Pulmonary artery systolic pressure (PASP) was calculated as the sum of the tricuspid jet gradient (assessed by Doppler) and right atrial pressure.
2.4. Definitions
Lead dependent tricuspid valve dysfunction was defined as significant or severe tricuspid regurgitation (or stenosis) resulting from the documented influence of the lead on the valve leaflets or chordae tendinae. LDTVD was recognized based on the visualization of one of the triggering mechanisms of TR: propping the leaflet by the lead or impingement of the leaflet by the lead or presence of the loop of lead irritating the TV or perforation of the leaflet with the lead.
Lead extraction procedure was defined according to the most recent guidelines on the management of lead-related complications (HRS 2017 and EHRA 2018) [
20,
21]. Indications for TLE and type of periprocedural complications were defined according to the 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction [
20].
2.5. Transvenous Lead Extraction Procedure
Most TLE procedures were performed using nonpowered mechanical systems such as Byrd polypropylene dilator sheaths (Cook Medical, Leechburg, PA, USA) if only possible via the implant vein. If technical difficulties arose, alternative venous approaches or additional tools such as Evolution (Cook Medical, Leechburg, PA, USA), TightRail (Spectranetix, Sunnyvale, CA, USA), lassos (Multi-Snare®Device PFM Medical, Inc. Carlsbad, CA, USA), basket catheters (Cook Medical Inc., Bloomington, IN, USA) were utilized. The excimer laser was not applied.
2.6. Indications for Transvenous Lead Extraction in Whole Examined Population of Patients
Main indications for TLE were: 1. infectious complications: local pocket infection, bacteraemia with or without endocarditis, or any combination of these presentations together 2 non-infectious indications including: mechanical lead damage (electric failure), lead dysfunction (exit/entry block, dislodgement, extracardiac pacing, perforation), upgrading, downgrading and another reasons of prevention of lead abandonment-prophylactic indications e.g. atrial fibrillation, overmuch of leads, threatener/potentially threatener lead (free ending, left heart, LDTVD and other (MRI indication, cancer, pain of pocket, loss of indication for pacing/ICD) and recapture venous access (symptomatic occlusion, superior vena cava syndrome, lead replacement/upgrading).
2.7. Statistical Analysis
The Shapiro–Wilk test showed that most continuous variables were normally distributed. For uniformity, all continuous variables are presented as the mean ± standard deviation and were compared using “U” Mann–Whitney test. Categorical data are presented as absolute numbers and percentages and were compared using Chi-square test with Yates correction.
Logistic linear regression was applied to identify the variables associated with LDTVD. To the univariable regression analysis were included demographic, clinical, echocardiographic, and CIED related (outside derivate) data which reached the p value < 0.1 in the “U” Mann–Whitney or Chi2 tests. To the multivariable regression analysis data reached p < 0.1 under univariable analysis were included.
The results of the regression analysis were reported as odds ratio with corresponding 95% confidence intervals (CIs).
Survival analysis based on Kaplan–Meier curves and log-rank tests were used to assess the event-free survival between groups of patients separated on the basis of LDTVD presence (divided in to two groups regarding on the TLE impact on the LDTVD).
The results were considered statistically significant if p < 0.05. Statistical analysis was performed with Statistica version 13.3 (TIBCO Software Inc., Palo Alto, CA, USA).
2.8. Approval of the Bioethics Committee
All patients gave their informed written consent to undergo TLE and use anonymous data from their medical records, approved by the Bioethics Committee at the Regional Chamber of Physicians in Lublin No. 288/2018/KB/VII. The study was carried out in accordance with the ethical standards of the 1964 Declaration of Helsinki.
3. Results
3.1. Baseline Characteristics
Among 2678 patients referred to TLE, 119 (4.44%) were diagnosed with LDTVD. Patients with LDTVD were referred for lead extraction for various reasons and only 37.82% of LDTVD was the primary indication of TLE. In as far as 62.18% LDTVD is diagnosed occasionally as important but co-existing indication. A common mechanism of LDTVD was propping upward or clamping (drawing) down the leaflet by the lead (85.71%); another mechanism as impingement of the leaflet by the lead presence (irritation and degeneration), perforation of the leaflet with the lead or connection of leaf with the lead with scar were rare (11.76%). In direct echocardiographic evaluation (TEE after procedure), improvement in TV function, defined as perceptible, was found in 27.73% of patients, in 10.92% it showed a significant improvement, while in 61.34% of patients it was not significant. The reduction of TR after TLE was observed in 35.29% of patients: a one-degree reduction in TR was diagnosed in 31.93% of patients, and a 2-degree reduction in 3.36% of patients.
A total of 40 patients out of 119 (33.60%) achieved the criterion of TV plastic, but only 18 (15.13%) were referred for surgery, the rest are under observation (
Table 1).
Patients with LDTVD tended to be older at the time of TLE (
p = 0.087) and more often of the female sex. LDTVD group was characterized by significantly higher incidence of valvular heart disease, presence of valvular implant and severe heart failure (NYHA Class III and IV). Patients with LDTVD were more likely to have permanent atrial fibrillation (AF), renal failure and used long-term anticoagulation (
Table 2).
Improvement in tricuspid valve function after TLE was observed in 42 patients with LDTVD, the remaining 77 did not show changes. The reduction in TR after TLE was found more frequently in older patient (in advanced age during implantation and during TLE) and in patients with ischemic heart disease (
Table S1—Supplementary File).
3.2. Pacing System and TLE-Related Factors
Indications for TLE in the entire study group included infectious complications in 31.52% of patients, non-infectious therapeutic indications in 65.10% and prophylactic indications in 3.40% of patients.
Patients with LDTVD were referred to TLE more frequently due to non-infectious therapeutic indications, less often due to infectious complications.
In terms of kind of implanted system, patients with LDTVD more often had pacemakers (AAI, VVI, DDD, CRT-P mode), less often ICD. Excessive loops of the leads passing through the TV were found more frequently in LDTVD group (20.17% vs. 4.53%; p = 0.001), similarly other forms of collision of the lead with TV visible in fluoroscopy (21.01% vs. 0.59%; p = 0.001).
The number of leads and number of abandoned leads was comparable in the studied groups.
Mean lead dwell time in the patient before TLE in the whole study group was 95.36 ± 67.10 months and was longer in patients with LDTVD (107.73 ± 68.90 vs. 95.83 ± 66.98 months; p = 0.058).
In patients with LDTVD, there was a tendency to more frequent non-apical location of the lead tip (
p = 0.092) (
Table 3).
Improvement of TV function after TLE was visible only in the group of non-infectious prophylactic indications. There was no association between implanted system-related factors and appearance of improvement in TV function after TLE (
Table S2—Supplementary File).
Complex (second line) tools such as Evolution, TightRail or lasso catheter were more often required when performing TLE procedures in patients with LDTVD—this was due to more frequent technical problems in this group of patients (10.08% vs. 4.42%;
p = 0.07). In the LDTVD group, tip or lead fragment retention was more frequent—partial radiological success was observed in 8.40% of patients compared to 3.63% in patients without LDTVD (
p = 0.014). The effectiveness of TLE and the percentage of major and minor complications did not differ significantly in the studied groups. Long-term mortality after TLE was comparable in the LDTVD group and without lead-dependent tricuspid valve dysfunction (
Table 4).
There was no direct relationship between the efficacy of TLE and the improvement in tricuspid valve function after procedure. Patients with improved tricuspid valve function after TLE showed a better long-term survival (
Table S3—Supplementary File).
3.3. Echocardiographic Findings
Patients with LDTVD more often demonstrated mitral valve insufficiency, greater dimension of the right ventricle (RV) and higher pulmonary systolic pressure (PASP). Left ventricular ejection fraction (LVEF) no differ significantly between compared groups. Significant and severe (Grade 3 and 4) tricuspid regurgitation was more frequently observed in patients with LDTVD (40.34%vs 14.10%; p = 0.001 and 47.90% vs. 2.74; p = 0.001).
In the LDTVD group more frequent occurred adhesion of the lead to the walls of the heart, especially to the tricuspid apparatus (14.29% vs. 4.85%;
p = 0.001) and more often were observed excessively elongated loops of the leads (similarly to fluoroscopy results) (36.13% vs. 17.60%;
p = 0.001) (
Table 5,
Figure 1).
There was a trend towards improvement of TV function after TLE in patients with a smaller right ventricular size (
p = 0.081). The remaining echocardiographic findings did not correlate with a reduction in TV regurgitation after TLE (
Table S4—Supplementary File).
3.4. Univariate and Multivariate Logistic Regression of Risk Factors for LDTVD
Univariate analysis showed, that factors predisposing to LDTVD were: female gender, valvular heart disease, presence of valvular implant, higher NYHA class, permanent AF, long-term anticoagulation, larger diameter of RV, higher PASP, and strong connective tissue scar connection of the lead with heart structures (TV, RA or RV). There was also a tendency to influence the mean lead dwell time (p = 0.062).The presence of only the pacing lead (no HV lead) also increased the probability of LDTVD.
The multivariate analysis confirmed the increased probability of LDTVD in female sex, patients with valvular heart disease, atrial fibrillation, heart failure with high NYHA class, larger RV and higher PASP and in case of collision of the lead with TV and strong connective tissue scar connection of the lead with heart structures especially with RA wall. The presence of only the pacing lead (no HV lead) also increased the probability of LDTVD (
Table 6).
Analysis of the survival showed better prognosis of patients with LDTVD with improvement of tricuspid valve function after TLE compared to the other LDTVD patients in short, mid and long-term follow up (
Figure 2).
4. Discussion
The prevalence of lead-dependent tricuspid valve dysfunction is assessed in wide ranges depending on the studied population and the follow-up period after CIED implantation. According to previous studies comparing valve function before and after implantation, deterioration of tricuspid regurgitation is found in 7–45% of patients in Period 1 month to 6.5 years [
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
15]. In the present study, the incidence of LDTVD was relatively low—4.44%, however, in the current analysis TV function before and after CIED implantation was not compared, only influence of the lead on TV at various times after implantation (average time was about 8 years) as well as possible reduction of TR and survival after lead extraction procedure.
The diagnosis of LDTVD is difficult and requires careful echocardiographic evaluation. It has been shown to be the most common mechanism in the present study were propping upward or clamping (drawing) down the leaflet by the lead (85.7%) (
Figure 3). A similar mechanism is presented as leading in the current reports [
15,
17].
The most frequently reported risk factors for LDTVD are: female sex, the presence of atrial fibrillation, history of open-heart surgery, pre-existing TR, right ventricular dilatation, mitral regurgitation, enlargement of the left atrium, the presence of a high voltage (HV) lead, a greater number of leads passing through the tricuspid orifice, the specific position of the lead in relation to the valve annulus, leaflets, chordae tendinae, the place of pacing in the right ventricle, echocardiographic evidence of leaflet interference and elevated preimplant tricuspid regurgitation pressure gradient [
6,
7,
15,
16,
17,
22,
23]. Analysis of the risk factors of LDTVD in the present study also showed a link between the female gender and some clinical factors: valvular heart disease permanent AF and heart failure. These factors do not initially cause LDTVD but are likely to increase the severity of LDTVD and worsen the NYHA class. The present study also showed a significant role for echocardiographic findings. In addition to factors considered in previous reports, such as dilation of the right ventricle and elevated PASP, a higher probability of LDTVD has also been shown in the case of collision of the lead with TV (especially excessive loop) and connective tissue adhesions of the leads with the cardiac structures: TV, RA or RV. The influence of an excessively long loop of the lead irritating the tricuspid valve on the development of LDTVD was already presented in an earlier study of the authors [
24]. The loop located in the tricuspid ostium, by persistent valve opening, contributes to the development of a significant TR, at the same time it grows into the tricuspid apparatus, often causing TV stenosis.
Several earlier reports have shown an influence of the time after CIED implantation on the development of LDTVD [
7,
15,
16,
17,
25]. In the present study, the effect of duration of the lead in the heart has not been proven, but it should be taken into account that mean lead dwell time in whole study population was very long (95.36 ± 67.10 months), and in the group of patients with LDTVD, it was significantly longer (107.73 ± 68.90;
p = 0.058). Undoubtedly, an expression of the influence of time on the development of LDTVD in the present study is the demonstration of the predictive role of the growth of leads to the structures of the heart.
Some studies document a close relationship between LDTVD and lead location that causes anterior or posterior leaflets impingement [
26,
27]. The course of the lead through the TV is also closely related to the target site of right ventricular pacing. In the formerly common apical pacing, the axial course through the TV is more favorable for a better cooptation of the leaflets. In turn, the currently more popular septal pacing may predispose to the occurrence of LDTVD through a much less axial course and a potential conflict with the chordae tendinae. In the present study, the tendency to more often LDTVD in patients with non-apical location of the lead tip was observed (
p = 0.09), meanwhile, previous studies show completely different results Some reports have documented the unfavorable effect of septal pacing on the development of LDTVD [
8,
28] while others suggest the opposite—adverse effect of apical pacing, probably related to contraction dyssynchrony [
9,
29].
The present study also looked at the possibility of improving tricuspid valve function in patients with LDTVD after TLE. The reduction of TR after TLE was demonstrated in 35.29% of patients and was found more frequently in elderly patients with ischemic heart disease, qualified for TLE for prophylactic indications, and in patients with a smaller right ventricular size. Reports on the improvement of valve function in patients with LDTVD after TLE are sparse, in fact only the authors’ previous analysis shows a significant reduction in TR [
24], Other studies do not confirm the improvement of TV function in these patients, attributing it to the dilation of the tricuspid valve annulus persisted following lead removal [
30,
31].
The relationship between LDTVD and worse survival is well known, and worsening of TR has been identified as an independent risk factor for mortality [
15,
16,
32,
33]. Analysis of long-term survival in the present study showed higher mortality in patients with LDTVD, but for the first time it was documented that this only applied to patients who did not improve after TLE. Patients with LDTVD who showed a decrease in TR after TLE had the best survival after approximately 5 years of follow-up.